Tumapon, Familia .
HRN: 13-17-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/23/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/23/2023
09/30/2023
IV
500mg
Q8 X 7 Days
Post OP Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes